Therapeutic Area | MeSH |
---|---|
infections | D007239 |
eye diseases | D005128 |
immune system diseases | D007154 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VALCYTE | CHEPLAPHARM Arzneimittel | N-021304 RX | 2001-03-29 | 1 products, RLD, RS |
VALCYTE | CHEPLAPHARM Arzneimittel | N-022257 RX | 2009-08-28 | 1 products, RLD, RS |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
aids-related opportunistic infections | — | D017088 | — |
cytomegalovirus infections | EFO_0001062 | D003586 | B25 |
cytomegalovirus retinitis | EFO_1001302 | D017726 | — |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cytomegalovirus infections | D003586 | EFO_0001062 | B25 | 3 | 7 | 12 | 5 | 8 | 32 |
Hiv infections | D015658 | EFO_0000764 | B20 | — | — | 3 | 1 | 1 | 5 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | — | 1 | — | 1 | 1 | 3 |
Infections | D007239 | EFO_0000544 | — | — | — | 1 | 2 | — | 3 |
Castleman disease | D005871 | EFO_1001332 | D47.Z2 | — | 1 | — | 1 | — | 2 |
Viremia | D014766 | — | B34.9 | — | 1 | — | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cytomegalovirus retinitis | D017726 | EFO_1001302 | — | — | — | 2 | — | 1 | 3 |
Sensorineural hearing loss | D006319 | HP_0000407 | H90.5 | — | 1 | 2 | — | — | 3 |
Pneumonia | D011014 | EFO_0003106 | — | — | 1 | 1 | — | — | 1 |
Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | 1 | 1 | — | — | 1 |
Heart transplantation | D016027 | EFO_0010673 | — | — | — | 1 | — | — | 1 |
Bone marrow transplantation | D016026 | — | — | — | — | 1 | — | — | 1 |
Cytomegalovirus | D003587 | — | — | — | — | 1 | — | — | 1 |
Ulcerative colitis | D003093 | EFO_0000729 | K51 | — | — | 1 | — | — | 1 |
Inflammatory bowel diseases | D015212 | EFO_0003767 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoproliferative disorders | D008232 | Orphanet_2442 | D47.9 | 1 | 4 | — | — | — | 4 |
Human herpesvirus 8 | D019288 | — | — | — | 3 | — | — | — | 3 |
Kidney transplantation | D016030 | — | — | 2 | 2 | — | — | 1 | 3 |
Glioblastoma | D005909 | EFO_0000515 | — | 1 | 2 | — | — | 1 | 3 |
Lymphoma | D008223 | — | C85.9 | — | 2 | — | — | — | 2 |
Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | — | 2 |
Hiv | D006678 | — | O98.7 | — | 2 | — | — | — | 2 |
Nasopharyngeal carcinoma | D000077274 | — | — | 2 | 1 | — | — | — | 2 |
Nasopharyngeal neoplasms | D009303 | — | — | 2 | 1 | — | — | — | 2 |
Kidney diseases | D007674 | EFO_0003086 | N08 | 2 | 2 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Liver transplantation | D016031 | EFO_0010682 | — | 1 | — | — | — | 1 | 2 |
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Idiopathic pulmonary fibrosis | D054990 | — | J84.112 | 1 | — | — | — | — | 1 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | — | — | — | — | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 1 | 1 |
Renal insufficiency | D051437 | HP_0000083 | N19 | — | — | — | — | 1 | 1 |
Myelodysplastic syndromes | D009190 | — | D46 | — | — | — | — | 1 | 1 |
Myeloid leukemia acute | D015470 | — | C92.0 | — | — | — | — | 1 | 1 |
Essential thrombocythemia | D013920 | — | D47.3 | — | — | — | — | 1 | 1 |
Polycythemia vera | D011087 | — | D45 | — | — | — | — | 1 | 1 |
Primary myelofibrosis | D055728 | — | D47.4 | — | — | — | — | 1 | 1 |
Multiple myeloma | D009101 | — | C90.0 | — | — | — | — | 1 | 1 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | — | — | — | — | 1 | 1 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | — | — | — | — | 1 | 1 |
Drug common name | Valganciclovir |
INN | valganciclovir |
Description | Valganciclovir is the L-valinyl ester of ganciclovir, into which it is rapidly converted by intestinal and hepatic esterases. It is a synthetic analogue of 2'-deoxyguanosine. It has a role as a prodrug and an antiviral drug. It is a member of purines and a L-valyl ester. It is functionally related to a guanine and a ganciclovir. |
Classification | Small molecule |
Drug class | antivirals: antivirals (acyclovir type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)[nH]c(N)nc21 |
PDB | — |
CAS-ID | 175865-60-8 |
RxCUI | — |
ChEMBL ID | CHEMBL1201314 |
ChEBI ID | 63635 |
PubChem CID | 135413535 |
DrugBank | DB01610 |
UNII ID | GCU97FKN3R (ChemIDplus, GSRS) |